Dementia: When is it not Alzheimer disease?

American Journal of the Medical Sciences

Volumn 324, Issue 2, 2002, Pages 84-95

  Vicioso, Belinda A ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Alzheimer disease; Cognitive impairment; Dementia; Memory

Indexed keywords

ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; ENALAPRIL; FELODIPINE;

ALZHEIMER DISEASE; BRAIN DISEASE; CEREBROVASCULAR DISEASE; CLINICAL FEATURE; CLINICAL TRIAL; CONFERENCE PAPER; DEGENERATIVE DISEASE; DEMENTIA; DEPTH PERCEPTION; DIAGNOSTIC APPROACH ROUTE; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; EARLY DIAGNOSIS; EPIDEMIOLOGICAL DATA; FRONTOTEMPORAL DEMENTIA; HISTORY OF MEDICINE; HUMAN; HYPERTENSION; LANGUAGE; LEWY BODY; MULTIINFARCT DEMENTIA; NEUROPSYCHOLOGICAL TEST; PREVALENCE; PRION DISEASE; TASK PERFORMANCE;

EID: 0036329346     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000441-200208000-00007     Document Type: Conference Paper

References (50)

1. Epidemiology of dementia: Concepts and overview
2. Incidence of dementia and probable Alzheimer's disease in a general population: The Framingham Study
3. The US economic and social costs of Alzheimer's disease revisited
4. Shattuck lecture-neurodegenerative diseases and prions
5. Utility of the apolipoprotein E genotype in the diagnosis of Alzheimer's disease. Alzheimer's Disease Centers Consortium on Apolipoprotein E and Alzheimer's Disease
6. Pathological correlates of late-onset dementia multicenter, community based population in England and Wales. Neuropathology Group of the Medical Research Council Cognitive Function and Ageing Study (MRC CFAS)
7. Diagnostic accuracy of Alzheimer's disease: A clinicopathological study
8. MRI correlates of dementia after first clinical ischemic stroke
9. Long-term predictor of cognitive outcome in a cohort of older people with hypertension
10. Longitudinal assessment of neurocognitive function after coronary-artery bypass surgery
11. Vascular involvement in cognitive decline and dementia: Epidemiologic evidence from the Rotterdam study and the Rotterdam scan study
12. Brain infarction and the clinical expression of Alzheimer disease: The Nun study
13. A population-based study on motor performance and white matter lesions in older women
14. Neuropsychological, psychiatric, and cerebral blood flow findings in vascular dementia and Alzheimer's disease
15. Differentiation of vascular dementia from AD on neuropsychological tests
16. Practice parameter: Diagnosis of dementia (an evidence-based review)
17. The association between mid-life blood pressure and late-life cognitive function: The Honolulu-Asia aging study
18. The effect of blood pressure control on cognitive function: The focus study [abstract]
19. Spectrum of Parkinson's disease, Parkinson's dementia and Lewy body dementia
20. Comparison of extrapyramidal signs in dementia with Lewy bodies and Parkinson's disease
21. Alzheimer's disease and Parkinson's disease: Distinct entities or extremes in a spectrum of neurodegeneration?
22. The Lund longitudinal dementia study: A 25-year perspective on neuropathology, Differential diagnoses and treatment
23. Evaluation of the NINCDS-ADRDA criteria in the differentiation of Alzheimer's disease and frontotemporal dementia
24. Morbidity and comorbidity in relation to functional status: A community-based study of the oldest old (90+ years)
25. Impairment of the ubiquitin-proteasome system by protein aggregation
26. Frontotemporal dementia: Genotypes, phenotypes and more problems to be solved
27. Underrecognition of dementia by caregivers cuts across cultures
28. Are memory complaints predictive for dementia?
29. A multicomponent intervention to prevent delirium in hospitalized patients
30. Practice parameter: Risk of driving and Alzheimer's disease (an evidence-based review)
31. An alphabetical WORLD, a new version of an old test
32. Neurocognitive screening of the geriatric patient
33. Clox: An executive clock drawing task
34. Screening for dementia in the outpatient setting: The time and change test
35. The reversible dementias: Do they reverse?
36. The role of routine laboratory studies and neuroimaging in the diagnosis of dementia: A clinicopathological study
37. High prevalence of cobalamin deficiency in elderly outpatients
38. Subclinical hyperthyroidism and the risk of dementia. The Rotterdam study
39. Distinction between preclinical AD and depression
40. Changes in cognitive functioning following treatment of late-life depression
41. The course of geriatric depression with "reversible dementia": A controlled study
42. Does computed tomographic brain imaging have a place in the diagnosis of dementia?
43. Vascular dementia, a new beginning: Shifting focus from clinical phenotype of ischemic brain injury
44. Neuroimaging in the dementia assessment: Is it necessary?
45. Do surgical brain lesions present as isolated dementia? A population-based study